PT  - JOURNAL ARTICLE
AU  - Haile, Simon
AU  - Nikiforuk, Aidan M.
AU  - Pandoh, Pawan K.
AU  - Twa, David D. W.
AU  - Smailus, Duane E.
AU  - Nguyen, Jason
AU  - Pleasance, Stephen
AU  - Wong, Angus
AU  - Zhao, Yongjun
AU  - Eisler, Diane
AU  - Moksa, Michelle
AU  - Cao, Qi
AU  - Wong, Marcus
AU  - Su, Edmund
AU  - Krzywinski, Martin
AU  - Nelson, Jessica
AU  - Mungall, Andrew J.
AU  - Tsang, Frankie
AU  - Prentice, Leah M.
AU  - Jassem, Agatha
AU  - Manges, Amee R.
AU  - Jones, Steven J. M.
AU  - Coope, Robin J.
AU  - Prystajecky, Natalie
AU  - Marra, Marco A.
AU  - Krajden, Mel
AU  - Hirst, Martin
TI  - Optimization of magnetic bead-based nucleic acid extraction for SARS-CoV-2 testing using readily available reagents
AID  - 10.1101/2021.03.09.21251364
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.09.21251364
4099  - http://medrxiv.org/content/early/2021/03/13/2021.03.09.21251364.short
4100  - http://medrxiv.org/content/early/2021/03/13/2021.03.09.21251364.full
AB  - The COVID-19 pandemic has highlighted the need for generic reagents and flexible systems in diagnostic testing. Magnetic bead-based nucleic acid extraction protocols using 96-well plates on open liquid handlers are readily amenable to meet this need. Here, one such approach is rigorously optimized to minimize cross-well contamination while maintaining sensitivity.Article Summary A scalable, non-proprietary, magnetic bead-based automated nucleic acid extraction protocol optimised for minimum cross-well contaminationCompeting Interest StatementMK has received grants/contracts from Roche, Hologic and Siemens paid to his institution unrelated to this work.Funding StatementSupport for this work was provided by contributions from the Provincial Health Services Authority, Genome BC/Genome Canada (202SEQ, 212SEQ, 12002, COV-088), the Canada Foundation for Innovation (20070, 30981, 30198) and the BC Knowledge Development Fund.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Clinical Research Ethics Broad at the University of British Columbia (IRB00001443) waived ethical approval for this study based on TCPS2 2018 Article 2.5: Quality assurance and quality improvement studies, program evaluation activities, and performance reviews, or testing within normal educational requirements when used exclusively for assessment, management or improvement purposes, do not constitute research for the purposes of this Policy, and do not fall within the scope of REB review. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData may be requested